Sigvotatug vedotin
Based on 1 Customer Validation
Sigvotatug vedotin (SGN-B6A; PF-08046047) is an ADC that targets integrin β-6 (ITGB6) via the human IgG1 monoclonal antibody Sigvotatug (HY-P990764) (EC50 = 0.9 nM) and exhibits cytotoxicity against a variety of integrin β-6-positive cancer cells through the tubulin polymerization inhibitor MMAE (HY-15162).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 98.42%
- CAS 番号: 2764774-91-4
- 分子量:150000 (average)
-
保管条件:Shipping with dry ice
-80°C, protect from light
生物活性
製品説明
IC50 & Target
[1]|
ITGB6 |
tubulin |
体外実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:BxPC-3 pancreatic carcinoma cells
-
Concentration:2 μg/mL
-
Incubation Time:30 minutes on ice (preincubation); 4 hours at 37 °C (internalization assessment)
-
Result:Localized as a halo of red staining on the BxPC-3 cell plasma membrane at time 0.
Colocalized with green-stained lysosomes (appearing as orange color in intracellular vesicles) by 4 hours.
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:nude mice (female, 5 to 8 weeks old)[1]
-
Dosage:1 mg/kg; 3 mg/kg
-
Administration:i.p.; weekly; 3 doses
-
Result:Showed dose-dependent anti-tumor activity, including the induction of tumor regression.
化学情報
-
CAS 番号 2764774-91-4
-
性状 Liquid
-
分子量 150000 (average)
-
Color Colorless to light yellow
-
SMILES
[Sigvotatug vedotin]
-
別名
SGN-B6A; PF-08046047
-
輸送条件
Shipping with dry ice.
-
保管条件
-80°C, protect from light
純度とドキュメンテーション
-
データシート (272 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
取扱説明書 (2659 KB)
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Sigvotatug vedotin
- 2764774-91-4
- SGN-B6A
- PF-08046047
- PF08046047
- PF 08046047
- PF-08046047
- Antibody-Drug Conjugates (ADCs)
- Integrin
- Microtubule/Tubulin
- Antibody-Drug Conjugates
- ADC
- integrin alpha-v/beta-6
- monomethyl auristatin E
- non-small cell lung carcinoma
- integrin beta-6-expressing carcinoma cells
- pancreatic carcinoma
- bladder carcinoma
- Detroit 562 cells
- cynomolgus monkeys
- lysosomal pathway
- BxPC-3 cells
- Inhibitor
- inhibitor
- inhibit